IngateyGen’s approach is to remove allergens at the source while keeping peanuts nutritionally similar to conventional ones. We use advanced breeding techniques to achieve this goal.
Phase 1: Using RNAi technology, we developed GMO peanuts with reduced allergen content.
Phase 2: We are now using CRISPR to create Non-GMO Allergen-Free Peanuts, making our peanuts safer while maintaining high quality.
Before introducing our peanuts to the wider market, we conducted carefully designed pilot studies. These studies helped us evaluate safety, acceptance, and performance under real-world conditions.
Our first pilot studies were carried out in controlled research environments, where we tested the modified peanuts for allergen reduction and nutritional quality while monitoring for any unintended effects.
We also collaborated with schools and food service providers to explore how safer peanuts could be integrated into everyday meals. Feedback from families and institutions helped refine both our product and approach.
Login as
Login as